Lloyd Rowland, Sr. V.P. and General Counsel at Xencor, holds 117.73K shares in CytomX Therapeutics (Ticker: CTMX), holds 1.50K shares in Xencor (Ticker: XNCR). Most recently, Lloyd Rowland Sold ― shares of CytomX Therapeutics on Mar 21, 2024 for an estimated value of 10.96K.